- socially bharat
- October 7, 2024
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
CHALFONT ST GILES, England: Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium